Douglas Carr Century Therapeutics, Inc. (IPSC) insider trading activity

Douglas Carr is SVP Finance & Operations of Century Therapeutics, Inc.. Currently has a direct ownership of 405,982 shares of IPSC, which is worth approximately $235,469. The most recent transaction as insider was on Jun 09, 2025, when has been sold 4,904 shares (Common Stock) at a price of $0.62 per share, resulting in proceeds of $3,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 406K

1.26% 3M change

21.43% 12M change

Total Value Held $235,469

Douglas Carr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2025	SELL Open market or private sale	$3,040 $0.62 p/Share	4,904 Reduced 1.19%	405,982 Common Stock
May 05 2025	SELL Open market or private sale	$162 $0.55 p/Share	295 Reduced 0.07%	410,886 Common Stock
Mar 11 2025	BUY Grant, award, or other acquisition	-	95,625 Added 18.87%	411,181 Common Stock
Mar 10 2025	SELL Open market or private sale	$768 $0.62 p/Share	1,240 Reduced 0.39%	315,556 Common Stock
Feb 03 2025	SELL Open market or private sale	$273 $0.78 p/Share	351 Reduced 0.11%	316,796 Common Stock
Nov 04 2024	SELL Open market or private sale	$348 $1.23 p/Share	283 Reduced 0.09%	317,147 Common Stock
Nov 01 2024	SELL Payment of exercise price or tax liability	$20,929 $1.26 p/Share	16,611 Reduced 4.97%	317,430 Common Stock
Aug 05 2024	SELL Open market or private sale	$528 $1.83 p/Share	289 Reduced 0.09%	334,041 Common Stock
Jun 07 2024	BUY Grant, award, or other acquisition	-	17,007 Added 4.84%	334,330 Common Stock
May 03 2024	SELL Open market or private sale	$799 $3.11 p/Share	257 Reduced 0.08%	317,323 Common Stock
Mar 07 2024	BUY Grant, award, or other acquisition	-	14,000 Added 4.22%	317,580 Common Stock
Feb 06 2024	SELL Open market or private sale	$2,500 $4.49 p/Share	557 Reduced 0.18%	303,580 Common Stock
Feb 05 2024	SELL Open market or private sale	$2,469 $3.84 p/Share	643 Reduced 0.21%	304,137 Common Stock
Nov 01 2023	SELL Payment of exercise price or tax liability	$24,750 $1.49 p/Share	16,611 Reduced 5.17%	304,780 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	120,846 Added 27.33%	321,391 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	15,000 Added 6.96%	200,545 Common Stock

Douglas Carr

SVP Finance & Operations

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Value

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Century Therapeutics, Inc.

Track Activities on IPSC

Account